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Chronic pain is a significant health issue that affects approximately 50 million adults

3

in the United States. Traditional interventions are not always an effective treatment
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strategy for pain control. However, the wide adoption of smartphones and the rapid
growth of health information technologies over the past decade have created opportunities to use mobile health (mHealth) applications (apps) for pain tracking and
self‐management. In this PRISMA‐compliant systematic review, we assessed the
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components and determine the efficacy of these interventions for persons with
based on methodological guidelines from the Joanna Briggs Institute. We included

College of Nursing, University of Tennessee
Knoxville, Knoxville, Tennessee, USA

articles reporting original data on mHealth interventions with pain intensity as a
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criteria. Most of the interventions included feasibility or pilot studies, and all studies

interventions. Of the original 4959 articles, only five studies met the eligibility
were published between 2015 and 2018. Two of the five studies used visual analog
scales. Only two of the studies reported statistically significant pain intensity
outcomes, and considerable heterogeneity between the studies limited our ability
to generalize findings or conduct a meta‐analysis. Research investigating the
components and efficacy of pain‐related mHealth apps as interventions is an
emerging field. To better understand the potential clinical benefits of mHealth apps
designed to manage pain, further research is needed.
KEYWORDS

pain, health problems/pathological states/disease categories, information systems, systems
research/multisystem issues, computers/technology, systems research/patterns of care,
self‐care, functional ability/restoration

Res Nurs Health. 2021;44:111–128.

wileyonlinelibrary.com/journal/nur

© 2020 Wiley Periodicals LLC

|

111

112

|

MARTIN

ET AL.

Pain is a complex phenomenon and arguably one of the most dis-

psychoeducational interventions empower individuals to enhance

ruptive conditions prompting consumers to seek medical and self‐

their quality of life (Barlow & Ellard, 2004; Elgar & McGrath, 2003).

management advice from healthcare professionals (Portelli & Eldred,

Yet specific barriers, such as geography, limited trained professionals,

2016). Inherently subjective, pain is defined as an “unpleasant sen-

and high costs often increase disparities in access to appropriate

sory and emotional experience associated with, or resembling that

therapies (Lynch et al., 2008; Peng et al., 2007; Stinson et al., 2013).

associated with, actual or potential tissue damage” (International

Studies frequently report the inadequate management of pain and

Association for the Study of Pain, 2020) that is either a symptom of a

estimate that 30%–50% of individuals in the United States are un-

specific medical diagnosis or an idiopathic condition without an

dertreated (Deandrea et al., 2008; Greco et al., 2014).

identifiable pathophysiologic origin. Pain is often described in terms

Mobile health (mHealth) applications (apps) have emerged as

of its duration, acute or chronic. Acute pain usually does not last

one potential, cost‐effective strategy to provide approaches to

longer than 3–6 months and typically includes postoperative pain or

track and facilitate the self‐management of pain (Devan et al., 2019;

pain associated with broken bones, burns, and lacerations, or labor

Hernandez Silva et al., 2019; Scott et al., 2019). mHealth apps may

and delivery (Cleveland Clinic, 2017). Chronic pain is ongoing—

increase the potential to positively influence patient‐reported pain

lasting longer than 6 months—and includes neuropathic (e.g., per-

outcomes (World Health Organization, 2011). Between 2011 and

ipheral neuropathy, central neuropathic pain) or idiopathic (e.g.,

2019, the number of Americans with smartphones grew from 35%

headache, secondary fibromyalgia) pain, or pain associated with

to 81% (“Mobile Fact Sheet,” 2019), and 96% of Americans now own

cancer,

a cell phone. As of 2015, 62% of smartphone owners used their

arthritis,

or

musculoskeletal

conditions

(Cleveland

Clinic, 2017).
Compounding the complexity of pain is its high prevalence across

devices to seek health information, making this a more frequent use
of smartphones than online banking, job seeking, or identifying

all age groups in the United States. Approximately 20.4% (50 million)

government services (Smith, 2015). In 2017, the number of mHealth

of adults experience chronic pain, and 8.0% (19.6 million) of adults

apps surpassed 300,000. Approximately 40% of health‐related apps

experience high‐impact chronic pain that interferes with daily life

with self‐management components promote healthy lifestyles

most days or every day (Dahlhamer et al., 2018). Upwards of

(mHealth Economics 2017—Current Status and Future Trends in

15%–25% of children and adolescents suffer from pain‐related con-

Mobile Health, 2017; Thurnheer et al., 2018). Specific components

ditions (Groenewald et al., 2015). Chronic pain is associated with

allow individuals to track symptoms, activities, and nutrition

significant distress, decreased quality of life, impaired physical and

(Larson, 2018), as well as to engage in self‐assessments, education,

mental function, and increased risk of suicide (Ilgen et al. 2010, 2013;

social support, coaching, and communication with healthcare pro-

Ilgen et al., 2008). Acute pain, particularly postoperative or proce-

viders (e.g., clinical decision support; McKay et al., 2018; Slater

dural pain, is of increasing interest because of the opioid epidemic

et al., 2017; Slattery et al., 2019). Pain‐specific self‐management

(Institute of Medicine of the National Academies, 2011; National

components include skill support, pain education, self‐monitoring,

Academies of Sciences, Engineering, 2017). Both chronic and acute

social support, and goal setting (Lalloo et al., 2015).

pain have lasting impacts on individuals' lived experience: influencing

The number of apps specifically focused on pain is rapidly

social networks, communities, and society at large. The financial cost

growing; there exists upwards of 300 pain apps with self‐

of pain, including healthcare costs and lost productivity, accounts for

management components (Bhattarai et al., 2018). App components,

between $560 and $635 billion annually in the United States (Gaskin

or features, are defined by developers as entry points through which

& Richard, 2012). Pediatric chronic pain alone is responsible for

a consumer engages with apps (“Application Fundamentals|Android

nearly $11.8 billion in total healthcare expenditures in the United

Developers,” 2019). Common self‐management components include

States (Groenewald et al., 2015; Martin & Zeltzer, 2018).

skill support, pain education, self‐monitoring, social support, and goal

Given the physical, emotional, societal, and economic ramifica-

setting (Lalloo et al., 2015; Rosser & Eccleston, 2011). The growth of

tions of acute and chronic pain in the United States, there is a

mHealth apps that specifically target pain conditions raises questions

pressing need to treat, manage, and prevent pain using a bio‐

regarding how to enhance and measure the efficacy of these apps.

psychosocial framework (Portelli & Eldred, 2016). This framework

To the best of our knowledge, there have been six systematic

extends beyond pathophysiology and emphasizes the roles that

reviews since 2015. Three of these reviews appraised the quality of

biology, psychology, and social factors have on pain outcomes (Vetter

self‐management components of pain‐related apps (Devan et al.,

et al., 2013). This emphasis is essential because “[p]ain is never the

2019; Lalloo et al., 2015; Portelli & Eldred, 2016); one review eval-

sole creation of our anatomy or physiology. It emerges only at the

uated the self‐management components and the efficacy of the apps

intersection of bodies, minds and cultures” (Morris, 1991, p. 3).

on reducing pain (Nicholl et al., 2017); and two reviews assessed the

Often, healthcare providers in the United States medically

effectiveness of apps in reducing pain (Slattery et al., 2019;

manage acute pain with pharmacologic remedies but manage chronic

Thurnheer et al., 2018). Lalloo et al. (2015), Slattery et al. (2019),

pain using a holistic approach, with both pharmacologic and non-

Portelli and Eldred (2016), and Devan et al. (2019) evaluated apps

pharmacologic modalities. Self‐management mechanisms are essen-

found in app stores. Nicholl et al. (2017), Thurnheer et al. (2018), and

tial to managing chronic pain (McGillion et al., 2008; Palermo et al.,

Slattery et al. (2019) evaluated apps used as interventions in re-

2010; Stinson et al., 2009). In particular, behavioral and face‐to‐face

search settings.
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While Nicoll et al. (2017), Thurnheer et al. (2018), and Slattery

addressing pain. Pain intensity is arguably the most immediate

et al. (2019) evaluated apps used in research settings, all were no-

clinically relevant outcome. The intensity of pain must be addressed

tably different from our review and from each other in critical ways.

before issues surrounding broader aspects of pain, such as quality of

Perhaps, most significantly, the populations of interest varied be-

life, can be considered.

tween the studies. While both our review and Thurnheer et al. (2018)

Thus, to better understand the impacts of apps on reducing pain

focused on both acute and chronic pain broadly, Nicholl et al. (2017)

intensity in individuals participating in U.S.‐based research settings

only included lower back pain, and Slattery et al. (2019) did not

and the self‐management components of mHealth pain apps, this

consider acute pain. Slattery et al. (2019) also excluded all pediatric

systematic review of the literature aimed to address the following

studies, focusing on an exclusively adult population, while we were

questions: (1) What is the efficacy of mHealth apps on persons with

interested in pediatric and adult populations. To acknowledge the

pain?, and (2) What components of mHealth apps are used to manage

unique nature of the U.S. healthcare system and patient experiences

acute and/or chronic pain?

within that system, particularly with regard to pain management as
noted above, we included only research studies conducted in the
United States. In contrast, reviews by both Slattery et al. (2019) and

1 | METHO DS

Thurnheer et al. (2018) included international studies.
The nature of the interventions studied varied significantly

We developed our systematic review framework using guidance from

across these reviews. Thurneer et al. (2018) included apps on

the Joanna Briggs Institute. The institute places systematic reviews

smartphones or computer tablets but excluded other monitoring

on a continuum, situated between evidence generation (i.e., original

devices, such as FitBits or smartwatches, which is not aligned with

research, expertise, and scholarly discourse) and evidence transfer

established definitions of mHealth. Nicholl et al. (2017) reflected the

(i.e., active dissemination, systems integration, and education; Joanna

established definitions of mHealth; however, they excluded all stu-

Briggs Institute, 2016). This framework highlights the role of evi-

dies that did not have an interactive component that interfaced with

dence synthesis in connecting original research to patient care and is

healthcare providers. In contrast, Slattery et al. (2019) adopted a

aligned with our overall research objectives. We further refined our

broader definition of interventions. The authors evaluated mobile

research focus using the PICOT format, as described in Table 1. We

apps along with a variety of other eHealth pain modalities (e.g.,

registered the protocol for this systematic review a priori in PROS-

internet‐based, telephone‐supported, and videoconferencing tech-

PERO (Bakker et al., 2020; National Institute for Health Research,

nologies) used in remote or telehealth settings. We intentionally

n.d.; Registration Number: CRD4202013059).

chose to adopt well‐established definitions of mHealth as our defi-

For this review, we used the following definition of mHealth:

nition and inclusion criteria and decided to focus on mHealth as

“medical and public health practice supported by mobile devices,

opposed to eHealth to reflect the specific considerations of this

such as mobile phones, patient monitoring devices, personal digital

emerging area of interest, rather than telehealth interventions

assistants, and other wireless devices” (World Health Organization,

broadly.

2011, p. 6). We further defined the components of the apps based on

Finally, we assessed the efficacy of apps based on pain intensity

the activity or function they facilitated: education (i.e., consumer

outcomes, often measured through the use of visual analog or nu-

health information delivered via text or multimedia); clinical decision

meric scales, as “[a] simple measure of pain intensity may be the most

support (algorithms facilitating decision making by either the provi-

logical primary outcome variable” (Younger et al., 2009, p. 3). The

der or the patient; Martínez‐Pérez et al., 2014; Mork & Bach, 2018);

three other reviews included any pain measurement, including in-

reminders (i.e., push notifications, text messages); and communica-

tensity, frequency, and quality of life. Thurnheer et al. (2018) re-

tion (bidirectional real‐time or asynchronous interaction between

ported these measures as a single outcome described as pain

patients and providers).

improvement. The potential conflation of multiple aspects of pain

We included studies with acute or chronic pain intensity as a

poses challenges for accurately assessing an app's efficacy in

primary or secondary outcome and defined pain intensity as the

T A B L E 1 Research focus and eligibility
criteria expressed in PICOT format

Category

Eligibility criteria

Population

Participants who received an mHealth intervention in the United States and
did not receive a multimodal intervention (e.g., acupuncture, music
therapy, surgery for pain management)

Intervention

mHealth application, defined as the use of mobile and wireless devices to
improve health outcomes, healthcare services, and health research

Comparison

Any comparison, including no treatment

Outcomes

Pain intensity, defined as the magnitude of pain experienced

Types of studies

Both randomized and non‐randomized studies published since 2010
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magnitude of pain experienced. While healthcare professionals and

We compiled and deduplicated the search results in EndNote X7

consumers assess pain intensity through a variety of measures, the

(“EndNote,” 2019); and completed two levels of screening using

most commonly used measures include visual analog scales, numeric

Rayyan (“Ouzzani et al., 2016; Rayyan QCRI,” 2016). First, two in-

rating scales, and verbal rating scales, all of which yield relatively

dependent reviewers screened all titles and abstracts. We excluded

consistent findings (Jensen & Karoly, 2001). These measures are

studies with participants who did not receive an mHealth interven-

widely adopted in a range of clinical settings, easy to administer, and

tion or with interventions based outside of the United States to re-

familiar to patients. We chose pain intensity instead of other pain

flect the aforementioned unique features of the U.S. healthcare

scales (e.g., quality of life) through a consensus‐based process given

system, particularly regarding pain management. We excluded arti-

its frequency of use and its broad clinical implications.

cles published in a language other than English that did not describe

We conducted a comprehensive literature search based on ear-

U.S.‐based interventions, and articles that did not present original

lier piloting of terminology, definitions, and processes. We included

data, such as narrative reviews or opinion pieces. To minimize po-

both natural language and controlled vocabulary in compliance with

tential confounding, we also excluded articles if participants received

MECIR standards (Higgins et al., 2016), and our search strategy re-

multimodal interventions, such as acupuncture, music therapy, or

flected concepts of mHealth and pain. See Appendix 1 for a complete

surgical interventions to decrease pain.

search strategy. We executed the search across five databases: Ovid

Next, two independent reviewers screened full texts and re-

Medline, Ovid Embase, Cochrane Library via Wiley, CINAHL via

solved discrepancies through consensus. We report reasons for ex-

EBSCO, and Scopus. We did not exclude articles based on study

clusion at this phase in Figure 1, in compliance with PRISMA

design and included articles published after 2010 to align with the

standards (Moher et al., 2009). The first author developed data ex-

introduction of smartphones to the general market in the mid‐ to

traction and risk of bias forms piloted by the other group members

late‐2000s. A medical librarian developed and executed the search

for further refinement. We used Research Electronic Data Capture

with input from all group members. We completed the search in

(REDCap) software for data extraction purposes (Harris et al. 2009,

April 2019.

2019), and QualtricsXM software for evaluating the risk of bias, using

FIGURE 1

PRISMA flow diagram [Color figure can be viewed at wileyonlinelibrary.com]
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F I G U R E 2 Assessment of risk of bias items for the quasi‐
randomized studies

tools created by the Joanna Briggs Institute (The Joanna Briggs Institute 2017a, 2017b, 2017c). Two independent reviewers completed
all data extraction and risk of bias assessments.

2 | RESULTS
2.1 | Study characteristics

F I G U R E 5 Summary of risk of bias items for the randomized
controlled trial

In total, we retrieved 4959 unique articles, of which we excluded
4793 during the first level of screening. Of the 166 full‐text articles

study had a low risk of bias in all areas (Mollard & Michaud, 2018),

reviewed, we deemed five articles eligible for the final analysis

while the other four studies had at least two elements of bias,

(Bakshi et al., 2017; Fortier et al., 2016; Irvine et al., 2015; Jamison

deeming them either moderate or high risk of bias (Bakshi et al.,

et al., 2018; Mollard & Michaud, 2018). See Figure 1 for the selection

2017; Fortier et al., 2016; Irvine et al., 2015; Jamison et al., 2018).

flow diagram and Table 2 for the study characteristics. Dates of

Bias was most frequently due to lack of a control group, lack of

publications ranged from the years 2015 to 2018. Four of the five

blinding, and allocation concealment. See Table 2 for a summary of

studies were feasibility/pilot designs (Bakshi et al., 2017; Fortier

the risk of bias assessments and Appendix 2 for the full assessments

et al., 2016; Jamison et al., 2018; Mollard & Michaud, 2018); of which,

(Figures 2–7).

one utilized a mixed‐methods approach (Mollard & Michaud, 2018),

The intervention duration varied from 10 days (Fortier et al.,

and one was a randomized controlled trial (Irvine et al., 2015). One

2016) to 18 months (Bakshi et al., 2017), with two of the five studies lasting 6 months (Jamison et al., 2018; Mollard & Michaud,
2018). For all studies, recruitment occurred in the clinic, hospital, or

FIGURE 6

Assessment of risk of bias items for the case report

FIGURE 7

Summary of risk of bias items for the case report

F I G U R E 3 Summary of risk of bias items for the quasi‐
randomized studies

F I G U R E 4 Assessment of risk of bias items for the randomized
controlled trial

8 weeks

Irvine
Randomized
et al., 2015
controlled trial

e

10 days

Fortier
Feasibility/pilot
et al., 2016

Intervention
duration

18 months

Design

Bakshi
Feasibility/pilot
et al., 2017

Study

T A B L E 2 Study characteristics
Study inclusion criteria

Outpatient
(intervention)

a

Outpatient
(recruitment)

f

‐Diagnosed with cancer

‐Discuss the development of Pain
Buddy

Outpatienta
(intervention)

‐Cleared of medical risks by an
online screening survey

‐Respond to an online video
demonstrating that they had
access a computer

‐Have a working email address

‐Experiencing low back pain
within the past 3 months

‐Employed at least half time at a
collaborating companies

‐Living in the US

‐Evaluate the efficacy of a mobile‐web ‐18–65 years of age
app (FitBack) to manage and
prevent nonspecific low back pain

‐English speaking

‐Present the feasibility and preliminary ‐Currently undergoing cancer
outcomes data from a pilot study
treatment

‐8–18 years of age

‐Access to a smartphone or a
computer with internet

‐12–22 years of age

‐Initial evaluation of a tablet‐based
program, Pain Buddyd

‐Test the applicability of novel pain
metricsc

‐Determine the feasibility of electronic ‐Sickle cell disease
capture of longitudinal outpatient
pain in patients with sickle cell
disease

Study purpose, objectives,
and/or aims

Clinic, hospital
(recruitment)

Outpatienta
(interventionb)

Clinic, outpatient
(recruitment)

Recruitment and
intervention settings

‐Participating in a monitored
exercise program for
back pain

‐History of medical care for
back pain or prescription
medications for back pain

‐Experiencing back pain so
intense it interfered with
everyday life

‐Cognitive or developmental
delays

‐Cognitive difficulties

Study exclusion criteria

Moderate

Moderate

Moderate

Risk of bias
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6 months

‐Any clinically unstable
medical conditions

‐Chronic pain for more than 6
months

‐Own a smartphone

‐Determine usability barriers

‐Able to read and speak English

‐Actively seeing a rheumatology
provider at the researchers'
university rheumatology
clinic

‐Determine if app improves pain
outcomes

Clinic, outpatienta
(intervention)

‐Own a study‐compatible
smartphone (iPhone or
Android)
‐NR

‐Psychiatric or substance
abuse disorders that would
interfere with participation

‐Speaks and understands English ‐Significant visual or motor
impairments

‐Any significant cognitive
impairments

Study exclusion criteria

‐Over 18 years of age

Study inclusion criteria

‐Gather preliminary data to determine ‐Over 18 years of age
if a mobile app with hand optical
imaging capabilities improves self‐
management behaviors

‐Determine the feasibility, tolerability,
safety, and efficacy of a
smartphone pain app

Study purpose, objectives,
and/or aims

Clinic (recruitment)

Clinic, hospital
(intervention)

Clinic, hospital
(recruitment)

Recruitment and
intervention settings

Low

High

Risk of bias

a

Abbreviations: NR, not reported; US, United States.
Outpatient = home.
b
Analyses included both outpatient and hospital data.
c
Novel pain metrics included (1) proportion of pain free days [number of days without pain divided by total number of reported days] (2) 90th percentile of maximum daily pain (MDP) scores [MDP score >0 is
the number of days with pain] (3) Standard Deviation (SD) of MDP scores and (4) coefficient of variation of MDP scores (SD/mean).
d
Pain Buddy is aimed to enhance pain management and foster improved quality of life.
e
Study intervention (including prompts/emails) = 8 weeks; total duration of measurements = 16 weeks.
f
Outpatient = work.

Feasibility/pilot,
mixed‐
methods

Mollard and
Michaud,
2018

Intervention
duration

6 months

Design

(Continued)

Jamison
Feasibility/pilot
et al., 2018

Study

TABLE 2
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2.3 | Intervention characteristics and application
functionality

hospital setting for one study (Jamison et al., 2018); the clinic and
outpatient setting for one study (Mollard & Michaud, 2018); and an

All five studies reported pain interventions delivered using mobile or

outpatient location for three studies (Bakshi et al., 2017; Fortier

smart devices, and three studies reported delivery via web‐based

et al., 2016; Irvine et al., 2015).

modalities (Bakshi et al., 2017; Fortier et al., 2016; Irvine et al., 2015).

The overall purpose, objectives, or aims of the five studies varied

All but one study (Mollard & Michaud, 2018) used an mHealth app

widely: one study aimed to determine the feasibility of electronically

designed by the research team. All of the studies' mHealth apps in-

capturing novel pain metrics through a web‐based mobile or smart-

cluded a touchscreen interface and multiple features. The types of

phone app (Bakshi et al., 2017); one study presented feasibility and

content, in addition to pain assessments, varied: three apps in-

preliminary outcomes data from an initial pilot evaluating a tablet‐

corporated educational features (Fortier et al., 2016; Irvine et al.,

based program to enhance pain management (Fortier et al., 2016);

2015; Jamison et al., 2018), three incorporated reminders (Bakshi

one study assessed the efficacy of a mobile‐web app used to manage

et al., 2017; Irvine et al., 2015; Jamison et al., 2018), four included

and prevent pain (Irvine et al., 2015); one study aimed to determine

features to facilitate communication between the provider and the

the feasibility, tolerability, safety, and efficacy of a pain app delivered

consumer (Bakshi et al., 2017; Fortier et al., 2016; Jamison et al.,

via a mobile or smartphone (Jamison et al., 2018); and one study

2018; Mollard & Michaud, 2018), and one incorporated decision

investigated usability barriers and attempted to determine if an app

support capabilities (Bakshi et al., 2017).

with hand optical imaging capabilities improved pain outcomes and

All mHealth interventions included in this review were multi-

self‐management behaviors (Mollard & Michaud, 2018). Eligibility

component, designed to capture electronic pain assessments and

criteria varied across the five studies, with three studies requiring

promote participant engagement through components to commu-

access to a smartphone, and one study requiring access to a com-

nicate with healthcare providers or encourage self‐management of

puter (Bakshi et al., 2017; Jamison et al., 2018; Mollard & Michaud,

pain. The type and frequency of communication varied greatly. In two

2018). Eligible participants of the five studies included children and

studies, providers communicated with consumers via text messages

adolescents (Bakshi et al., 2017; Fortier et al., 2016) as well as adults

(Bakshi et al., 2017) or provided recommendations via web portals

(Irvine et al., 2015; Jamison et al., 2018; Mollard & Michaud, 2018).

(Fortier et al., 2016) if certain pain thresholds were met. In one study,

See Table 2 for study characteristics.

the mHealth app was integrated with an electronic medical record to
allow for the sharing of information with providers in real‐time;
however, the authors did not describe the ramifications of this

2.2 | Participant characteristics

component in detail (Jamison et al., 2018). Another study collected
self‐management and self‐efficacy data, but providers analyzed these

The sample sizes varied widely, from the smallest intervention group

data on an intermittent basis to facilitate clinical decisions rather

consisting of 12 children and adolescents (Fortier et al., 2016) to the

than using the data in real‐time (Mollard & Michaud, 2018).

largest group, including 597 adults (Irvine et al., 2015). Three studies

Three studies (Fortier et al., 2016; Irvine et al., 2015; Jamison

included intervention groups only (Bakshi et al., 2017; Fortier et al.,

et al., 2018) incorporated educational resources, cognitive and be-

2016; Jamison et al., 2018). One feasibility/pilot study included a

havioral strategies, and/or pain management strategies. These three

control group (Mollard & Michaud, 2018), and the randomized con-

studies were the only studies with additional non‐intensity pain

trolled trial had a control group and an alternative treatment group

measures, possibly indicating a preference for a holistic assessment

(Irvine et al., 2015). The overall ages of the participants ranged from

of pain and its associated symptoms (Fortier et al., 2016; Irvine et al.,

eight (Fortier et al., 2016) to 79 years (Jamison et al., 2018), although

2015; Jamison et al., 2018).

two of the studies did not report age (Irvine et al., 2015; Mollard &

Three of the apps were not theory‐based (Bakshi et al., 2017;

Michaud, 2018). Of the four studies that reported gender (Bakshi

Jamison et al., 2018; Mollard & Michaud, 2018). Fortier et al. (2016)

et al., 2017; Fortier et al., 2016; Irvine et al., 2015; Jamison et al.,

employed cognitive and behavioral skills training and social learning

2018), over half of the participants were female (61%). Participants'

theory, and Irvine et al. (2015) used the theory of planned behavior

pain diagnoses included sickle cell disease (Bakshi et al., 2017), leu-

and social cognitive theory. Social cognitive theory, also known as

kemia and tumors of the central nervous system (Fortier et al., 2016),

social learning theory, posits that individuals' health behaviors are

back pain (Irvine et al., 2015), cancer and noncancer pain (Jamison

influenced by experiences, others' actions, and the environment

et al., 2018), and rheumatoid arthritis (Mollard & Michaud, 2018). See

(Bandura, 1986). See Table 4 for intervention characteristics.

Table 2 for full details of the studies' eligibility criteria. Race/ethnicity was reported in four of the five studies (Bakshi et al., 2017;
Fortier et al., 2016; Irvine et al., 2015; Jamison et al., 2018), but only

2.4 | Intervention measures and outcomes

one article additionally reported income, education, and the employment status of its participants. See Table 3 for participant

Two of the five studies used visual analog scales to measure pain on a

characteristics.

1–10 scale (Jamison et al., 2018) or a 0–10 scale (Mollard & Michaud,
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T A B L E 3 Participant characteristics
Gender

Study

Sample Size
(total = N; subgroup = n)

Age

n

Bakshi et al., 2017

N = 20a

Median: 16

Female

Range:

%

13–21 15

Pain diagnos(es)

Race/ethnicity, income, education,
employment reported? (Yes/No)

‐Sickle cell disease

Race/ethnicity:

Yes

Income:

No

Education:

No

Employment:

No

Race/Ethnicity:

Yes

Income: No

No

Education:

No

Employment:

No

(75%)

Male
5
Fortier et al., 2016

N = 12

b

(25%)

Mean:

12.33

Female

SD:

(3.42)

5

Range:

8–18

Male

(42%)

7
Irvine et al., 2015

N = 597

b

‐NR

358

n = 199d

Male

e

n = 199
Jamison et al., 2018

N = 90

Mollard &
Michaud, 2018

N = 36

‐Nonspecific back pain

(40%)

Mean:

46.7

Female

SD:

(12.9)

58

Range:

19–79 Male

‐NR

‐NR

‐Tumors of the central
nervous system

(60%)

239

32
a

(58%)

Female

n = 199c

b

‐Leukemia

(64%)

‐Chronic pain
(cancer &
noncancer pain)

(36%)
‐Rheumatoid arthritis

f

n=2

n = 15

g

Race/ethnicity:

Yes

Income:

Yes

Education:

Yes

Employment:

Yes

Race/ethnicity:

Yes

Income:

No

Education:

No

Employment:

No

Race/ethnicity:

No

Income:

No

Education:

No

Employment:

No

Abbreviations: NR, not reported; SD, standard deviation.
Size based on per protocol analyses
b
Size based on intent to treat analyses
c
Treatment group
d
Alternative care group
e
Usual care control group
f
Intervention group
g
Control group
a

2018); the former was the Brief Pain Inventory (Jamison et al., 2018).

Three studies included within‐group analyses (Bakshi et al.,

Additionally, one study used a numeric rating scale (Bakshi et al., 2017),

2017; Fortier et al., 2016; Jamison et al., 2018), one study included

one study used the Adolescent Pediatric Pain Tool (Fortier et al., 2016),

between‐group analyses (Mollard & Michaud, 2018), and one study

and one used an adaptation of the Wong‐Baker FACES scale (Irvine

included both within‐group and between‐group analyses (Irvine et al.,

et al., 2015). See Table 5 for intervention measures and outcomes.

2015). Additional nonintensity pain measures included: Symptom

All studies reported that pain data were captured manually by

Measure (Fortier et al., 2016); Survey of Pain Attitudes, Tampa Scale

consumers. Frequency of pain measurements varied from one time per

for Kinesiophobia (Irvine et al., 2015); and Pain Relief, Pain Disability

day to three times per day in four of the five studies (Bakshi et al., 2017;

Index, and Pain Catastrophizing Scale (Jamison et al., 2018).

Fortier et al., 2016; Irvine et al., 2015; Jamison et al., 2018), and at least
one time per month for one study (Mollard & Michaud, 2018). Only two
of the five studies reported statistically significant pain intensity findings

3 | D IS C U S S I O N

(Irvine et al., 2015; Jamison et al., 2018). Irvine et al. (2015) found that
compared to the intervention group, the control group was 1.7 times

3.1 | Principal findings

more likely to report back pain (p = .02), and the alternative care group
was 1.6 times more likely to report back pain (p = .035). Jamison et al.

This systematic review examined the components of mHealth apps

(2018) found that average pain intensity decreased from 6.2 to 5.5 on a

used to manage acute and chronic pain and the apps' efficacy in

10‐point scale between baseline and 6 months (p < .01).

reducing pain intensity. Despite a comprehensive search process that
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T A B L E 4 Intervention characteristics and application functionality
Intervention

Components

Study

Type of app: (Device)

Designer:

Interface:

Bakshi
et al., 2017

‐Mobile

(Any device)

Researcher

Touchscreen Pain assessment:

‐Web‐based

(Computer)

Fortier
et al., 2016

‐Mobile

(Android device,
tablet)

‐Web‐based

(Participant
interface)

Researcher

‐Other

Irvine
et al., 2015

Jamison
et al., 2018

Mollard &
Michaud,
2018

‐Mobile

(Any device)

‐Web‐based

(Computer, tablet,
and mobile
devices)

‐Mobile

(Android, iPhone)

‐Wearable

(Fitbit)

‐Mobile

‐NR

Researcher

Researcher

Commercial
developers

Component type:

Theory‐based?

Yes/No

Intervention or
app/tool

Yes/No

Yes

Intervention:

No

Education:

No

Decision support:
Reminders:
Communication:

No
Yes
Yesa

App/tool:

No

Yes

Intervention:

Yese

App/tool:

Yesf

Intervention:

Yesg

Touchscreen Pain assessment:

Education:

Yes

Decision support:

Yesb

Reminders:
Communication:

No
Yesb

Touchscreen Pain assessment:

Yes

Education:

Yes

Decision support:
Reminders:
Communication:

No
Yes
No

App/tool:

Yesg

Touchscreen Pain assessment:

Yes

Intervention:

No

Education:

Yes

Decision support:
Reminders:
Communication:

No
Yes
Yesc

App/tool:

No

Yes

Intervention:

No
No

Touchscreen Pain assessment:
Education:

No

Decision Support: No
Reminders:
No
Communication:
Yesd

App/tool:

a

Pain level thresholds determined the level at which healthcare providers sent text messages to participants
Alert algorithms prompted text messages alerting healthcare providers to provide recommendations to participants via health portals
c
Information was integrated with electronic medical records
d
Information was used in face‐to‐face visits between healthcare provider and participants
e
Cognitive and behavioral skills training
f
Social learning theory
g
Theory of planned behavior, social cognitive theory
b

yielded 4959 articles, only five studies were deemed eligible. This

including ease of use and participant satisfaction, with a secondary

paucity of literature may indicate that mHealth interventions re-

focus on pain intensity outcomes and other quality of life measures.

porting pain‐related outcomes remain an emerging area of research,

As efficacy is generally not the primary focus of feasibility studies,

or as one previous systematic review noted, “a strategic field without

the state of the science is not well‐suited to answer our original

a scientific soul” (De La Vega & Miró, 2014, p. e101312).

research questions. However, the effectiveness of an intervention is

Four of the five articles in this review were feasibility/pilot

arguably the primary concern of both providers and consumers.

studies with a primary focus on the acceptability of the app,

While user acceptability is essential from a design perspective, the

Adaptation of Wong‐Baker FACES ‐NR

Irvine et al., 2015

At minimum 1 time per
monthi

‐NR

Mollard &
Michaud, 2018
No

Yesg

Yese

No

No

Statistically significant
outcomes (Yes/no)?

Between‐group

a

‐NR

‐Pain Catastrophizing Scale

‐Pain Disability Index

‐Pain Interferenceh

‐Tampa Scale for Kinesiophobiaf

Between‐group
Within‐group

‐Survey of Pain Attitudes

‐Memorial Symptom Assessment
Scalec

‐NR

Within‐group

Within‐group

Within‐group

Type of data analysis
Additional nonintensity pain
(within‐or between‐group)? measures mentioned?

Abbreviation: NR, not reported.
Measures included in analyses need to be, at minimum, 4 hours apart
b
Prompted to report pain using this tool only if first reported pain on a Memorial Symptom Assessment Scale
c
Two scales were used for different age groups: 7–12 years of age and 10–18 years of age
d
Outcome measures include three time points: pretest, postintervention (8 weeks after pretest), and postintervention (16 weeks after pretest)
e
Control group = 1.7 times more likely to report current back pain (p = .02); alternative care group = 1.6 times more likely to report current back pain (p = .035)
f
Pain Catastrophizing Scale
g
Average pain intensity decreased from baseline to 6 months (6.2–5.5; p < .01)
h
Subset of the Pain Disability Index
i
Measured pain monthly when instructed to use the imaging technology

Visual analogue scale (0–10)

1 time per day

Yes

1 time per dayd

Up to 2 times per day

Jamison et al., 2018 Brief Pain Inventory(visual
analogue scale,1–10)

Yes

Adolescent Pediatric Pain Tool
(word‐graphic rating scale)b

Fortier et al., 2016

3 times per daya

‐NR

Numerical rating scale (0–10)

Bakshi et al., 2017

Frequency of
measurements

Validated
(Yes/No)?

Scale type:

Study

Pain intensity scale:
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subordinate emphasis on pain and quality of life makes it difficult to

influence access to and comfort with technology (“Mobile Fact

assess the clinical utility of the mHealth apps and to evaluate the

Sheet,” 2019; Sipior et al., 2011). As such, consumer characteristics

overall efficacy of the mHealth interventions. We determined that

are essential considerations in the design and implementation of

four of the five studies had a moderate or high risk of bias and

mHealth apps.

found significant heterogeneity between the studies, including

Although there were significant differences in participant popu-

study populations, pain diagnoses and symptomatology, measures

lations and reporting details, the studies generally employed strin-

of reported pain, and intervention duration. This heterogeneity

gent inclusion and exclusion criteria. Four studies required that

limited our ability to conduct a meta‐analysis and subsequently

participants have access to a smartphone or a computer (Bakshi

make comparisons between studies. Moderate and high risk of bias

et al., 2017; Fortier et al., 2016; Jamison et al., 2018; Mollard &

in mHealth interventions is not surprising due to the inability to

Michaud, 2018); three studies excluded participants with cognitive

blind participants. We expected the heterogeneity because pain can

impairments (Bakshi et al., 2017; Fortier et al., 2016; Jamison et al.,

be a symptom of an underlying condition, as was the case in four of

2018); and three studies required that participants speak English

the studies (Bakshi et al., 2017; Fortier et al., 2016; Jamison et al.,

(Bakshi et al., 2017; Jamison et al., 2018; Mollard & Michaud, 2018).

2018; Mollard & Michaud, 2018), or it can be a diagnosis, as was the

Such stringent eligibility criteria limit the generalizability of the

case in one study (Irvine et al., 2015).

findings and lend to selection bias, as disparities in technology

Beyond the diagnostic complexity of pain, the experience of

adoption usually exist among lower‐income Americans (“Mobile Fact

pain, which is “an ongoing multifactorial process influenced by

Sheet,” 2019). Mobile tools “are developed predominantly by white,

physical, psychological and social factors” (Vellucci, 2012, p. 3), is

educated middle class professionals … who design systems and pro-

inherently subjective and individual, posing challenges for its mea-

cesses which they see as being appropriate and user‐friendly” (Sho-

surement. The research highlighted these challenges, as the studies

well & Turner, 2013, p. 278).

employed a range of scales to assess pain intensity. Each of the five

All of the apps were multicomponent. While there were some

studies used a different scale to measure pain intensity, only two of

commonalities amongst the components employed, the intention of

which were validated (Fortier et al., 2016; Jamison et al., 2018). The

these components in the context of the study aims appears to differ.

underutilization, or the lack of reporting of previously validated

For example, all studies included a component that would allow for

pain assessment scales by other researchers, is of interest given the

pain assessment. However, while three of the studies (Irvine et al.,

range and quantity of measures that exist. In addition to measures

2015; Jamison et al., 2018; Mollard & Michaud, 2018) treated pain

of pain intensity, three studies included additional pain‐related

measurement as a primary outcome, aiming to assess the efficacy of

measures to capture impact and frequency, as well as other non‐

the intervention, one study (Fortier et al., 2016) focused on a de-

pain related measures of symptoms, quality of life, and self‐efficacy

scription of the development process. In contrast, one study (Bakshi

(Fortier et al., 2016; Irvine et al., 2015; Jamison et al., 2018). The

et al., 2017) focused on the applicability of novel pain metrics.

utilization of these additional measures also illustrates the com-

Although there were some similarities in app components and

plexity of pain, with physical symptoms often accompanied by

intervention goals across studies, there were some disconnects. For

psychological and emotional symptoms that cannot be measured by

example, Mollard and Michaud (2018) aimed to assess the app's

pain intensity scales (Fortier et al., 2016). The subjective experience

potential to improve self‐management behavior and pain outcomes.

of pain further problematizes standardized pain assessment stra-

Yet, the app did not include an educational component or reminders

tegies. While psychological and physiological factors impact the

to help facilitate the adoption of self‐management behaviors or en-

experience of pain, recall bias lends itself to an overestimation of

gagement with the app. Similarly, Irvine et al. (2015) sought to de-

the severity of past pain experiences (Bruehl et al., 2012; Sorbi

termine their app's efficacy in managing and preventing lower back

et al., 2006). Retrospective reporting of pain may inflate pain in-

pain, but the authors did not describe any decision support or com-

tensity scores, and evidence shows that real‐time data collection

munication components.

using mHealth apps may be more accurate than paper‐based as-

The studies did not provide in‐depth rationales for why re-

sessments (Bakshi et al., 2017; Fortier et al., 2016). Hence, there is a

searchers selected specific app components for development or how

burgeoning interest in managing pain through mHealth tools that

they aligned with the overall study goals. Assessments of efficacy

are convenient and readily available.

were also conducted for the apps in their entirety rather than iso-

The inconsistencies in the reporting of participant characteristics

lating the individual components. As a result, it was not possible to

across studies limited the studies' methodological quality and the

determine the potential implications of specific app components on

implications of their findings. Four of the studies reported participant

overall pain intensity or to assess a particular component's con-

gender and race/ethnicity, three reported age, but only one study

tribution in meeting the studies' stated objectives. Future research

reported income, education, or the employment status of its parti-

should consider how to effectively isolate app components to de-

cipants (Irvine et al., 2015). Participant characteristics are important,

termine the efficacy of these distinct components on the pain out-

especially given that research has found that lower education and

comes of the participants.

income levels are associated with increased pain severity among in-

While only two of the apps were explicitly theory‐based, re-

dividuals with chronic pain (Booher, 2019). Demographic factors

searchers should not overlook the impact of social cognition theory
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on the development of mHealth technologies and health promotion

searched a variety of databases, and two independent reviewers

(Portelli & Eldred, 2016). As mHealth solutions are driven by the

screened abstracts and full texts. Pairs completed data extraction,

premise that consumers can remotely manage certain health condi-

analyses, and quality appraisals, and a third party served as an arbitrator

tions, independent of a provider, and “[s]elf‐management operates

if needed. We used validated critical appraisal tools, adhered to the

through a set of psychological subfunctions. People have to learn to

recommendations set forth by PRISMA and the Joanna Briggs Institute,

monitor their health behavior and the circumstances under which it

and preregistered our study to ensure its transparency and rigor.

occurs, and how to use proximal goals to motivate themselves and
guide their behavior” (Bandura, 2004, p. 151). This theory postulates
that both a sense of self‐efficacy—or confidence in executing an

3.3 | Clinical implications

action—and the resultant actions are significant determinants of both
acquiring and maintaining behaviors (Bandura, 1978). Individuals

Despite the independent nature of using mHealth apps to monitor and

may avoid actions or behaviors they believe to be beyond their

self‐guide behaviors to manage pain, there are several nursing oppor-

abilities, and they may be less likely to persevere or employ a range

tunities to support and enhance consumer success with improved pain

of coping strategies to address difficulties. Although Fortier et al.

management. The findings of these studies articulate several of these

(2016) and Irvine et al. (2015) explicitly noted this theoretical basis,

opportunities. Nurses are well‐positioned to help consumers learn how

the underpinning is so pervasive in mHealth development that it is

to engage with the apps and devices (Irvine et al., 2015; Mollard &

not unreasonable to speculate that it may have influenced the deci-

Michaud, 2018), supporting the individuals' comfort in adopting the

sion to include specific components in the other apps.

technologies. Nurses are also well‐positioned to encourage individuals

In line with the findings of previous systematic reviews, our

to continue using the apps after initial adoption (Irvine et al., 2015;

findings illustrate the need for more research. The clinical utility of

Jamison et al., 2018). mHealth interventions represent another channel

pain‐related apps is limited (Nicholl et al., 2017; Scott et al., 2019;

for communication with individuals (Irvine et al., 2015) and create op-

Slattery et al., 2019; Thurnheer et al., 2018); there is a lack of

portunities for nurses to monitor the consumers' symptoms and beha-

evidence‐based self‐management components (Lalloo et al., 2015;

viors over time (Bakshi et al., 2017; Fortier et al., 2016). Because of their

Portelli & Eldred, 2016); and there is a need for increased colla-

potential role in facilitating the adoption and ongoing use of mHealth

boration between app developers, clinicians, and consumers when

interventions, nurses have a critical role in determining the applicability

developing and evaluating app efficacy (Devan et al., 2019).

and efficacy of these interventions. Mobile apps are easily accessible,
yet healthcare professionals rarely play a role in the design and development of mHealth technologies (Devan et al., 2019). Currently,

3.2 | Strengths and limitations

consumer‐based mHealth apps that involve logging events, retrieval of
medical information, or communication with providers do not require

The main limitations of this review were the sparse literature related

approval from the Food and Drug Administration (US Food & Drug

to our research questions as well as the heterogeneity of findings

Administration, 2019). Therefore, nurses should be involved in design-

that limited our ability to compare pain outcomes and app compo-

ing and developing evidence‐based apps.

nents across interventions. These limitations may be a result of the
narrow focus of this review, resulting from the intentional exclusion
of usability studies that did not report pain‐related outcomes and

3.4 | Conclusions

telehealth interventions that did not meet our definition of mHealth.
Although we intended to understand the efficacy of the mHealth

In this review, we found that the mHealth apps used various com-

apps on reducing pain, we excluded studies that did not report pain

ponents to manage pain; however, we were unable to determine the

intensity as a primary or secondary outcome, and we did not evaluate

efficacy of the apps on decreasing pain intensity. Although the stu-

other nonintensity pain scales. We chose to focus on pain intensity as

dies' researchers designed multicomponent pain‐related apps and

it is one of the most frequently assessed aspects of pain in a broad

tested them in interventions, the apps were not entirely grounded in

range of clinical settings. However, not evaluating these other scales

evidence. To better understand the clinical benefits of mHealth apps

fails to provide a comprehensive representation of the pain experi-

designed to track pain and facilitate self‐management behaviors,

ence. Finally, we chose to include only English‐language publications

future research should test the apps' efficacy and simultaneously

and U.S.‐based interventions due to the different healthcare systems

examine whether specific app components are more efficacious than

and pain management strategies internationally. While such restric-

others. Our findings suggest that future interventions should include

tions were necessary to address our research questions more accu-

large sample sizes and rigorous designs—such as randomized con-

rately, these limitations led to fewer eligible articles.

trolled trials or multiphase optimization (MOST) strategies—to better

Despite these limitations, this systematic review has many

understand each component's role in reducing pain (PennState,

strengths. We designed the research using an iterative process and

2020). Researchers should not limit measures to pain intensity, as the

followed a rigorous methodology aligning with best practices, and our

addition of other measures (e.g., quality of life, pain interference) may

team included a range of clinical and research perspectives. We

yield a more holistic assessment of the pain experience.
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Q7. Were the outcomes of participants included in any comparisons measured in the same way?
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Q8. Were outcomes measured in a reliable way?
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Q9. Was appropriate statistical analysis used?
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Q1. Was true randomization used for assignment of participants

Tobago" or Tunisia or Turkey or Turkmenistan or Tuvalu or

to treatment groups?
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Q11. Were outcomes measured in a reliable way?
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Q12. Was appropriate statistical analysis used?

Q1. Is it clear in the study what is the "cause" and what is the

Q13. Was the trial design appropriate, and any deviations from

"effect" (i.e., there is no confusion about which variable comes first)?

the standard RCT design (individual randomization, parallel groups)

Q2. Were the participants included in any comparisons similar?
Q3. Were the participants included in any comparisons receiving
similar treatment/care, other than the exposure or intervention of
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accounted for in the conduct and analysis of the trial?
Items for Figure 5.
Q1. Was true randomization used for assignment of participants
to treatment groups?

Q4. Was there a control group?

Q2. Was allocation to treatment groups concealed?

Q5. Were there multiple measurements of the outcome both pre

Q3. Were treatment groups similar at the baseline?

and post the intervention/exposure?
Q6. Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and
analyzed?
Q7. Were the outcomes of participants included in any comparisons measured in the same way?
Q8. Were outcomes measured in a reliable way?

Q4. Were participants blind to treatment assignment?
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analyzed?

Q1. Is it clear in the study what is the "cause" and what is the
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Q2. Were the participants included in any comparisons similar?
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Q9. Were participants analyzed in the groups to which they were
randomized?
Q10. Were outcomes measured in the same way for treatment
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Q13. Was the trial design appropriate, and any deviations from
the standard RCT design (individual randomization, parallel groups)
accounted for in the conduct and analysis of the trial?
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a timeline?
Q3. Was the current clinical condition of the patient on presentation clearly described?
Q4. Were diagnostic tests or assessment methods and the
results clearly described?
Q5. Was the intervention(s) or treatment procedure(s) clearly
described?
Q6. Was the post‐intervention clinical condition clearly
described?
Q7. Were adverse events (harms) or unanticipated events
identified and described?
Q8. Does the case report provide takeaway lessons?
Items for Figure 7.
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described?
Q6. Was the postintervention clinical condition clearly described?
Q7. Were adverse events (harms) or unanticipated events
identified and described?
Q8. Does the case report provide takeaway lessons?

